Balanced news tone
News Sentiment
PRVA sentiment intelligence
Privia Health Group Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
51
Balanced news tone
58 relevant articles
News tone and price action are not far from neutral.
84/100 classification confidence.
directly relevant articles
high-authority source matches
+0.5% over one week, +17.3% over four weeks, trend active, and materially above fair value.
Price to book forward of Privia Health Group, Inc. – NASDAQ:PRVA
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
84/100 classification
One-week reaction
0.5%
Price digesting
Trend fit
Trend active
17.3% over four weeks
Fair value
25.1%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
8
Neutral
46
Negative
4
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
TradingView
Direct company coverage
Price to book forward of Privia Health Group, Inc. – NASDAQ:PRVA
This article provides financial data for Privia Health Group, Inc. (NASDAQ:PRVA), specifically focusing on its "Price to book forward" metric. It appears to be a stub or a data point from a financial platform like TradingView, indicating no current trades and listing basic financ
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 11:41
- Source
- TradingView
MT Newswires
Direct company coverage
Privia Health Group Insider Sold Shares Worth $588,679, According to a Recent SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 20:12
- Source
- MT Newswires
Stock Titan
Direct company coverage
Privia Health (PRVA) CFO Mountcastle sells 21,275 shares under 10b5-1 plan
Privia Health Group, Inc.'s CFO, David Mountcastle, sold 21,275 shares of company common stock in an open-market transaction under a Rule 10b5-1 trading plan. The shares were sold at a weighted average price of $27.67, totaling approximately $588,679. Following this transaction,
- Tone
- Negative 28/100
- Event
- Market update
- Published
- 13 Jul 2026 20:11
- Source
- Stock Titan
The Motley Fool
Direct company coverage
What Does a Privia Health Insider's Sale of Company Shares for $3.6 Million Mean for Investors?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 18:48
- Source
- The Motley Fool
Investing.com Nigeria
Direct company coverage
Form 144 Privia Health Group For: 9 July By Investing.com
Investing.com reports on a Form 144 filing for Privia Health Group on July 9th. The article is brief, containing only the headline and a Reuters copyright notice, indicating a routine disclosure of intent to sell restricted securities. It also includes the stock symbol PRVA and a
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 22:22
- Source
- Investing.com Nigeria
Stock Titan
Direct company coverage
David Mountcastle sells multiple PRVA shares (PRVA) including 24,734 on 07/02/2026
David Mountcastle, a reporting person for Privia Health Group, Inc. (PRVA), sold common shares on multiple dates, as detailed in Form 144 notices. These sales include 24,734 shares on July 2, 2026, for proceeds of $680,187.50, and 17,196 shares on June 26, 2026, for $433,036.65.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 21:41
- Source
- Stock Titan
Investing.com Canada
Direct company coverage
Form 4 Privia Health Group Inc For: 9 July By Investing.com
This article announces the filing of Form 4 for Privia Health Group Inc. on July 9th. It is a brief corporate news update provided by Investing.com, likely detailing insider transactions as reported on the Form 4. The main content indicates a financial disclosure relevant to the
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 20:41
- Source
- Investing.com Canada
Investing.com
Direct company coverage
Privia Health Group stock hits 52-week high at $27.71
Privia Health Group Inc. (PRVA) achieved a 52-week high of $27.71, with shares trading at $27.77, indicating strong performance with a 30.09% one-year change. Despite missing EPS expectations, the company exceeded revenue forecasts in Q1 2026 and shareholders approved all proposa
- Tone
- Positive 75/100
- Event
- Earnings
- Published
- 09 Jul 2026 20:41
- Source
- Investing.com
Stock Titan
Direct company coverage
Privia Health (PRVA) CFO sells 600 shares, keeps over 186K stake
Privia Health Group, Inc.'s EVP and CFO, David Mountcastle, sold 600 shares of common stock at a weighted average price of $27.57 per share under a pre-arranged Rule 10b5-1 trading plan. After this transaction, Mountcastle directly holds 186,128 shares and indirectly holds 8,695
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 09 Jul 2026 20:41
- Source
- Stock Titan
Moomoo
Direct company coverage
Press Release: Privia Health to Report Second Quarter 2026 Results on Thursday, August 6
Privia Health announced it will release its second-quarter 2026 financial results on Thursday, August 6, 2026. The company will host a conference call and webcast to discuss these results the same day. This announcement provides investors and the public with the schedule for its
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jul 2026 09:40
- Source
- Moomoo
The Manila Times
Direct company coverage
Privia Health to Report Second Quarter 2026 Results on Thursday, August 6
Privia Health Group, Inc. (Nasdaq: PRVA) announced it will release its financial results for the second quarter and six months ended June 30, 2026, before market open on Thursday, August 6, 2026. The company will also host a conference call at 8:00 am ET on the same day to discus
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jul 2026 07:41
- Source
- The Manila Times
Moomoo
Direct company coverage
Privia Health(PRVA.US) Director Sells US$3.08 Million in Common Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 20:10
- Source
- Moomoo
Investing.com Nigeria
Direct company coverage
Form 4 Privia Health Group Inc For: 7 July By Investing.com
This article reports on a Form 4 filing for Privia Health Group Inc. on July 7th, as published by Investing.com. It is a brief announcement indicating a regulatory filing has been made for the company. The article, however, mainly consists of market data, news headlines, and navi
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 07 Jul 2026 21:09
- Source
- Investing.com Nigeria
TradingView
Direct company coverage
Shawn Morris resigns from Privia Health Group board and compliance committee
Shawn Morris has resigned from Privia Health Group's Board of Directors and Compliance Committee, effective July 6, 2026. The company stated that his resignation was not due to any disagreement with their operations, policies, or practices. This information was based on an origin
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 20:41
- Source
- TradingView
Investing.com
Direct company coverage
Privia Health Group EVP & CFO David Mountcastle sells $680k in shares
David Mountcastle, EVP & CFO of Privia Health Group (NASDAQ:PRVA), sold 24,734 shares of company stock for approximately $680,185 on July 2, 2026, at an average price of $27.50 per share. This transaction occurred near the stock's 52-week high, with shares up 27% in the past year
- Tone
- Negative 40/100
- Event
- Market update
- Published
- 07 Jul 2026 20:41
- Source
- Investing.com
scanx.trade
Direct company coverage
Privia Health to report Q2 2026 results on August 6
Privia Health Group, Inc. is scheduled to announce its second-quarter and six-month financial results for 2026 on August 6, before market open. A conference call will follow at 8:00 am ET to discuss the results and future outlook. The company currently operates in 25 states and p
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Jul 2026 19:41
- Source
- scanx.trade
Stock Titan
Direct company coverage
Privia Health Group (PRVA) director reports 112,759-share option exercise and sale
Privia Health Group director Matthew Shawn Morris exercised options for 112,759 shares at $2.00 per share and subsequently sold them in open-market transactions on July 2 and July 6, 2026, at weighted average prices of $27.33 and $27.24, respectively. These sales were conducted u
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 19:41
- Source
- Stock Titan
Stock Titan
Direct company coverage
Board member Shawn Morris exits Privia Health (NASDAQ: PRVA) role
Privia Health Group, Inc. announced that Shawn Morris resigned from its Board of Directors and the Board’s Compliance Committee, effective July 6, 2026. The company stated that his departure was not due to any disagreement regarding operations, policies, or practices, and express
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 19:41
- Source
- Stock Titan
Stock Titan
Direct company coverage
Privia Health sets Aug. 6 earnings call and outlook update
Privia Health (Nasdaq: PRVA) announced it will release its second-quarter and six-month 2026 financial results before market open on Thursday, August 6, 2026. The company will host a conference call and live webcast at 8:00 am ET on the same day to discuss the results and provide
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Jul 2026 12:40
- Source
- Stock Titan
Stock Titan
Direct company coverage
Privia Health Group (PRVA) CFO sells 24,734 shares in planned trade
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 07:00
- Source
- Stock Titan
Sahm
Direct company coverage
3 Quality Stocks Built For A Pricey Market
This article identifies three quality stocks—TransMedics Group (TMDX), Privia Health Group (PRVA), and Savaria (SIS)—that are well-suited for a market with stretched valuations. These companies are highlighted for their strong fundamentals, consistent earnings, and effective risk
- Tone
- Positive 71/100
- Event
- Earnings
- Published
- 03 Jul 2026 10:40
- Source
- Sahm
Investing.com Nigeria
Direct company coverage
Form 144 Privia Health Group For: 2 July By Investing.com
This article reports on a Form 144 filing for Privia Health Group on July 2nd. It provides key financial metrics for various indices and commodities, including market performance and trading volumes. The piece also lists several trending and most actively traded stocks, alongside
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 06:39
- Source
- Investing.com Nigeria
MT Newswires
Direct company coverage
Privia Health Group Insider Sold Shares Worth $3,566,335, According to a Recent SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 20:06
- Source
- MT Newswires
Stock Titan
Direct company coverage
PRVA (NASDAQ: PRVA) insider sales reported, with restricted stock vesting noted
A recently filed Form 144 for Privia Health Group, Inc. (NASDAQ: PRVA) indicates sales by an affiliated holder and outlines several restricted stock vesting events across March, April, and May 2026. The filing also details multiple brokered sales by David Mountcastle from April t
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 20:39
- Source
- Stock Titan
Stock Titan
Direct company coverage
Director at Privia Health (PRVA) sells 135,498 shares after option exercise
Privia Health Group, Inc. director Matthew Shawn Morris reported exercising 135,498 stock options at $2.00 per share and subsequently selling 135,498 common shares in open-market transactions. These sales, totaling approximately $3.57 million, were conducted under a pre-arranged
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 19:39
- Source
- Stock Titan
Stock Titan
Direct company coverage
Privia Health (PRVA) director sells 151,322 shares after exercising options
Privia Health Group, Inc. (PRVA) director Matthew Shawn Morris sold 151,322 shares after exercising stock options on June 26 and June 29, 2026. The shares were acquired at $2.00 each and sold in open-market transactions at a weighted average price of approximately $25.33 per shar
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 04:40
- Source
- Stock Titan
Moomoo
Direct company coverage
Privia Health(PRVA.US) Director Sells US$3.83 Million in Common Stock
NULL
- Tone
- Negative 30/100
- Event
- Market update
- Published
- 01 Jul 2026 04:40
- Source
- Moomoo
MT Newswires
Direct company coverage
Privia Health Group Insider Sold Shares Worth $432,995, According to a Recent SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 20:17
- Source
- MT Newswires
MT Newswires
Direct company coverage
Privia Health Group Insider Sold Shares Worth $3,832,986, According to a Recent SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 20:12
- Source
- MT Newswires
Stock Titan
Direct company coverage
Privia Health (NASDAQ: PRVA) CFO sells 17,196 exercised shares
Privia Health's EVP & CFO, David Mountcastle, exercised options to acquire 17,196 shares of common stock at $2.00 per share and subsequently sold the same number of shares at a weighted average price of $25.18 per share. This transaction, executed on June 26, 2026, was conducted
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 19:40
- Source
- Stock Titan